Role of nanocomposites in drug delivery

Venkata Kamala Kumari Paravastu; Srinivasa Rao Yarraguntla; Akhila Suvvari

doi:10.30574/gscbps.2019.8.3.0150

Authors

Venkata Kamala Kumari Paravastu Vignan Institute of Pharmaceutical Technology Duvvada, Visakhapatnam.
Srinivasa Rao Yarraguntla Vignan Institute of Pharmaceutical Technology Duvvada, Visakhapatnam.
Akhila Suvvari Vignan Institute of Pharmaceutical Technology Duvvada, Visakhapatnam.

DOI:

https://doi.org/10.30574/gscbps.2019.8.3.0150

Keywords:

Nanocomposites, Polymer, Clay, Biomedical

Abstract

Nanocomposites have become a promising area of research and development. Nanocomposites are of two types: polymer nanocomposites and clay nanocomposites. In a large field of nanotechnology the polymer nanocomposites which can increase the mechanical properties have become a prominent area of current research and development. The clay nanocomposites increase the additional properties and have dominated the polymer literature. But there are a large number of other significant areas of current and emerging interest. The nanocomposites can be used as drug carriers due to their surface and rheological properties. This review will detail the technology involved with clay-polymer based nanocomposites and also include other important areas including barrier properties, flammability resistance, biomedical applications, electrical/ electronic applications and fuel cell interest.

Metrics

Metrics Loading ...

References

Kamigaito O. (1991). What can be improved by nanometer composites?. Journal of the Japan Society of Powder and Powder Metallurgy, 38(3), 315-321.

Prajapati SK, Maurya SD, Das MK, Tilak VK, Verma KK and Dhakar RC. (2016). Dendrimers in drug delivery, diagnosis and therapy: basics and potential applications. Journal of Drug Delivery and Therapeutics, 6(1), 67-92.

Okpala CC. (2013). Nanocomposites–an overview. Int. J. Eng. Res. Dev, 8(11), 17.

Suresh R, Borkar SN, Sawant VA, Shende VS and Dimble SK. (2010). Nanoclay drug delivery system. International Journal of Pharmaceutical Sciences and Nanotechnology, 3(2), 901-905.

Vaia RA. (2002). Polymer nanocomposites open a new dimension for plastics and composites (No. AFRL-ML-WP-TP-2005-408). Air force research lab wright-patterson AFB oh materials and manufacturing directorate.

De Sousa Rodrigues LA, Figueiras A, Veiga F, de Freitas, RM, Nunes LCC, da Silva Filho EC and da Silva Leite CM. (2013). The systems containing clays and clay minerals from modified drug release: a review. Colloids and Surfaces B: Biointerfaces, 103, 642-651.

Aguzzi C, Cerezo P, Viseras C and Caramella C. (2007). Use of clays as drug delivery systems: possibilities and limitations. Applied Clay Science, 36(1-3), 22-36.

Iliescu RI, Andronescu E, Voicu G, Ficai A and Covaliu CI. (2011). Hybrid materials based on montmorillonite and citostatic drugs: Preparation and characterization. Applied Clay Science, 52(1-2), 62-68.

Giannelis EP. (1996). Polymer layered silicate nanocomposites. Advanced materials, 8(1), 29-35.

Patel HA, Somani RS, Bajaj HC and Jasra RV. (2006). Nanoclays for polymer nanocomposites, paints, inks, greases and cosmetics formulations, drug delivery vehicle and waste water treatment. Bulletin of Materials Science, 29(2), 133-145.

Paul DR and Robeson LM. (2008). Polymer nanotechnology: nanocomposites. Polymer, 49(15), 3187-3204.

Meng N, Zhou NL, Zhang SQ and Shen J. (2009). Controlled release and antibacterial activity chlorhexidine acetate (CA) intercalated in montmorillonite. International Journal of Pharmaceutics, 382(1-2), 45-49.

Khalil, H, Mahajan D and Rafailovich M. (2005). Polymer–montmorillonite clay nanocomposites. Part 1: complexation of montmorillonite clay with a vinyl monomer. Polymer international, 54(2), 423-427.

Wang X, Du Y and Luo J. (2008). Biopolymer/montmorillonite nanocomposite: preparation, drug-controlled release property and cytotoxicity. Nanotechnology, 19(6), 065707.

Mohanambe L and Vasudevan S. (2005). Anionic clays containing anti-inflammatory drug molecules: Comparison of molecular dynamics simulation and measurements. The Journal of Physical Chemistry B, 109(32), 15651-15658.

Pharmacognosy CK and Kokate SB. (2007). Gokhale Eds., Nirali Prakashan, Pune, India, 39th ed.

Handbook of Pharmaceutical excipients, M.E. Quinn and R.C. Rowe Eds., Pharmaceutical press, USA, 6th ed., 2009.

Joshi GV, Patel HA, Kevadiya BD and Bajaj HC. (2009). Montmorillonite intercalated with vitamin B1 as drug carrier. Applied Clay Science, 45(4), 248-253.

Kevadiya BD, Thumbar RP, Rajput MM, Rajkumar S, Brambhatt H, Joshi GV and Bajaj HC. (2012). Montmorillonite/poly-(ε-caprolactone) composites as versatile layered material: Reservoirs for anticancer drug and controlled release property. European Journal of Pharmaceutical Sciences, 47(1), 265-272.

Hua S, Yang H and Wang A. (2010). A pH-sensitive nanocomposite microsphere based on chitosan and montmorillonite with in vitro reduction of the burst release effect. Drug development and industrial pharmacy, 36(9), 1106-1114.

Sharma R and Raina KK. (2011). Structural and Electrical studies on ferroelectric polymer nanocomposites (Doctoral dissertation).

Choy JH, Choi SJ, Oh JM and Park T. (2007). Clay minerals and layered double hydroxides for novel biological applications. Applied Clay Science, 36(1-3), 122-132.

Forest MG, Zhou R and Wang Q. (2004). Chaotic Boundaries of Nematic Polymers in Mixed Shear and ExtensionalFlows. Physical Review Letters, 93(8), 088301.

Nicholson BF, Clancy P and Rick SW. (2006). The interface response function and melting point of the prism interface of ice Ih using a fluctuating charge model (TIP4P-FQ). Journal of crystal growth, 293(1), 78-85.

Armstrong G and Kailas L. (2017). Hyphenated analytical techniques for materials characterization. European Journal of Physics, 38(5), 053001.